(S)-3-Hydroxypyrrolidine hydrochloride

We are (S)-3-Hydroxypyrrolidine hydrochloride CAS:122536-94-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(S)-3-Hydroxypyrrolidine hydrochloride
CAS.NO:122536-94-1
Synonyms:(S)-3-Hydroxypyrrolidine hydrochloride
(S)-Pyrrolidin-3-ol hydrochloride
(S)-3-Hydroxypyrrolidine Hydrochloride
(S)-(+)-3-Pyrrolidinol Hydrochloride
(3S)-pyrrolidin-3-ol,hydrochloride
 
Physical and Chemical Properties:
Boiling Point 224.7ºC at 760 mmHg
Melting Point 104-107ºC
Molecular Formula C4H10ClNO
Molecular Weight 123.581
Flash Point 105.8ºC
Vapour Pressure 0.018mmHg at 25°C
 
Specification:
Appearance:White powder
Assay(HPLC):98-102%
Residue on ignition:≤0.5%
Loss on drying:≤1.0%
Melting Point:104-107ºC
Specific rotation:+6.8°~+8.0°
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Darifenacin hydrobromide(CAS:133099-07-7) and Darifenacin(CAS:133099-04-4).

(S)-3-Hydroxypyrrolidine hydrochloride


Related News: ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.N-OCTYLMETHYLDIETHOXYSILANE From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.32858-93-8 Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.3-isocyanatopropyl(trimethoxy)silane CAS:15396-00-6 At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content.Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.

Related Products
Product Name
Thymosin β4 View Details
1-Chloro-2-iodoethane View Details
2-Amino-4-fluorobenzonitrile View Details
4-tert-Butylbenzylamine manufacturer 3,4-Dichlorobenzotrifluoride manufacturer ethyl 4-methoxy-3-oxobutanoate manufacturer 5-Chloroacetyl-6-chlorooxindole manufacturer 4-(trifluoromethyl)-1H-indole manufacturer